lopinavir has been researched along with chlorogenic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Chan, KH; Chen, F; Cheng, VC; Fan, KW; Guan, Y; Hung, IF; Jiang, Y; Kao, RY; Lee, TS; Lu, HT; Peiris, JS; Tsui, WH; Yuen, KY | 1 |
2 other study(ies) available for lopinavir and chlorogenic acid
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.
Topics: Adult; Antiviral Agents; Cell Line; Chlorogenic Acid; Drug Synergism; Female; Flavonoids; Glycyrrhizic Acid; Humans; Interferon beta-1a; Interferon-alpha; Interferon-beta; Lopinavir; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidinones; Ribavirin; Rimantadine; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Plaque Assay | 2004 |